Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non-Cross-Resistant Schedule. - Groen,H.JM.; Fokkema,E.; Biesma,B.; Kwa,B.; van Putten,J.WG.; Postmus,P.E.; Smit,E.F. (J Clin Oncol, 1999)